Blockchain Registration Transaction Record

Datavault AI Licenses Tech to Scilex for $2.5T Biotech Tokenization

Datavault AI grants Scilex exclusive license for biotech asset tokenization platform targeting $2T market. Includes $10M upfront plus $2.55B in potential milestone payments.

This partnership represents a significant convergence of artificial intelligence, blockchain, and biotechnology that could fundamentally transform how medical and scientific data is valued and monetized. For the healthcare industry, it introduces new pathways for biotech companies to access non-dilutive funding while creating more efficient markets for genomic data, diagnostic information, and drug development assets. Patients and researchers could benefit from accelerated innovation as valuable data becomes more accessible and tradable, potentially leading to faster drug discovery and personalized medicine advancements. The $2 trillion market opportunity indicates this technology could reshape financial models across the pharmaceutical sector, creating new revenue streams while addressing longstanding challenges in data sharing and collaboration within the highly regulated biotech industry.